Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Obstet Gynecol. 2012 Mar;119(3):631–639. doi: 10.1097/AOG.0b013e318244ed20

Table 3.

Seroconversion Rates by Trimester and Postpartum Period

Time Period Averaged Overall All Strains, All Years Pandemic H1N1 Only
n % Seroconverted* Odds Ratio 95% CI n % Seroconverted* Odds Ratio†† 95% CI
First trimester (less than 13 weeks) 73 54.8 0.48 (0.16, 1.41) 7 28.6 0.27 (0.03, 2.12)
Second trimester (13-less than 28 weeks) 183 62.8 0.76 (0.29, 2.05) 16 62.5 1.11 (0.22, 5.62)
Early third trimester (28-less than 34 weeks) 86 58.1 0.74 (0.26, 2.14) 10 60.0 1.00 (0.17, 5.98)
Late third trimester (34 weeks or more) 56 69.6 1.41 (0.43, 4.58) 8 87.5 4.67 (0.40, 53.95)
Immediate postpartum (less than 72 hours) 73 54.8 0.55 (0.18, 1.71) 3 66.7 Ref
Later postpartum (approximately 6 weeks) 36 69.4 ref 7 57.1

CI, confidence interval.

*

Crude seroconversion rate averaged over all strains and separately for pandemic H1N1

Adjusted for strain, baseline antibody titer, vaccination in the last year, age at vaccination, education, and obesity.

††

Unadjusted